Heartflow Inc. Common Stock (HTFL)
Stock · NASDAQ · Health Care
$48.23as of 10/16/2026
Price chart
Active signals
Support level
$28.87
Industry
Medical/Dental Instruments
About HTFL
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arterie…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 843
- Website
- www.heartflow.com/
Fundamentals
- 1-day range
- $47.39$51.84
- Market cap
- $2.34B
- P/E (trailing)
- —
- P/E (forward)
- -197.77
- EPS (trailing)
- $-1.82
- Dividend yield
- —
- Beta
- 1.62
- Avg. volume
- 1.81M
52-week range
$20.13$54.32
Next earnings: November 11, 2026 · EPS estimate $-0.10confirmed
How Heartflow Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 18, 2026 · via SEC EDGAR / Finnhub
Gross Profit$135.20M(77%)
Operating Income-$64.07M(-36%)
Forecasts
9 analyst ratings
Buy 87%
Hold 13%
Sell 0%
1-year price forecast
High
$56
+16.1%
Median
$45
-6.7%
Low
$39
-19.1%
Heartflow Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HTFLHeartflow Inc. Common Stock$48.29▼ 5.14%Market cap $2.34BP/E —$20.13$54.32
- UFPTUFP Technologies Inc. Common Stock$291.67▼ 1.86%Market cap $2.41BP/E 31.50$173.86$338.71
- XRAYDENTSPLY SIRONA Inc. Common Stock$8.57▼ 2.94%Market cap $2.64BP/E —$8.38$14.76
- PLSEPulse Biosciences Inc Common Stock (DE)$44.43▼ 2.54%Market cap $2.65BP/E —$12.56$58.9
- ATRCAtriCure Inc. Common Stock$56.07▼ 2.96%Market cap $2.01BP/E 261.42$25.36$61.7
- LMATLeMaitre Vascular Inc. Common Stock$80.82▼ 2.81%Market cap $1.85BP/E 29.17$78.22$118.01
- NVCRNovoCure Limited Ordinary Shares$14.07▼ 2.36%Market cap $1.83BP/E —$9.82$21.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HTFL Heartflow Inc. Common Stock | $2.34B | — | $48.29 | ▼ 5.14% | $20.13$54.32 |
| UFPT UFP Technologies Inc. Common Stock | $2.41B | 31.50 | $291.67 | ▼ 1.86% | $173.86$338.71 |
| XRAY DENTSPLY SIRONA Inc. Common Stock | $2.64B | — | $8.57 | ▼ 2.94% | $8.38$14.76 |
| PLSE Pulse Biosciences Inc Common Stock (DE) | $2.65B | — | $44.43 | ▼ 2.54% | $12.56$58.9 |
| ATRC AtriCure Inc. Common Stock | $2.01B | 261.42 | $56.07 | ▼ 2.96% | $25.36$61.7 |
| LMAT LeMaitre Vascular Inc. Common Stock | $1.85B | 29.17 | $80.82 | ▼ 2.81% | $78.22$118.01 |
| NVCR NovoCure Limited Ordinary Shares | $1.83B | — | $14.07 | ▼ 2.36% | $9.82$21.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Pfizer And 2 Other Top AI Healthcare StocksYahoo · 10/10/2026
- AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin ExpansionYahoo · 9/29/2026
- Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56benzinga · 9/22/2026
- Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56Benzinga · 9/22/2026
- BCSM Exits Heartflow (HTFL) on Competitive ConcernsYahoo · 9/17/2026
- HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week HighYahoo · 9/15/2026
- HeartFlow, Inc. (HTFL) Presents at Wells Fargo 21st Annual Healthcare Conference - SlideshowSeekingAlpha · 9/11/2026
Insider Activity
Insider Actions →Acquired
13.2K
Disposed
217.9K
- Campbell Rogers · September 18, 2026 · Option Exercise850 @ $2.22
- Campbell Rogers · September 18, 2026 · Option Exercise12.3K @ $8.33
- Campbell Rogers · September 18, 2026 · Sale19.7K @ $50.15
- Vikram Verghese · September 18, 2026 · Sale16.8K @ $50.75
- Vikram Verghese · September 17, 2026 · Sale7.6K @ $50.11
- Vikram Verghese · September 15, 2026 · Sale668 @ $50.01
- Vikram Verghese · September 14, 2026 · Sale4.6K @ $50.24
- Vikram Verghese · September 11, 2026 · Sale29.7K @ $50.06
- John C.M. Farquhar · September 11, 2026 · Sale3.9K @ $50
- John C.M. Farquhar · September 10, 2026 · Sale35.0K @ $46.42
- Vikram Verghese · September 8, 2026 · Sale6.6K @ $50.03
- Vikram Verghese · September 3, 2026 · Sale27.5K @ $49.69
- Vikram Verghese · September 2, 2026 · Sale5.9K @ $50.6
- John C.M. Farquhar · August 21, 2026 · Sale27.2K @ $50
- John C.M. Farquhar · August 18, 2026 · Sale32.7K @ $45
Institutional Ownership
March 31, 2026
- Total shares held
- 62.34M
- Total value held
- $1.51B
- Institutional holders
- 162
Top holders this quarter
- Unknown11.98M
- Unknown10.45M
- Unknown5.40M
- Unknown3.83M
- Unknown2.18M
- Unknown1.91M
- Unknown1.89M
- Unknown1.46M
- Unknown1.41M
- Unknown1.22M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Heartflow featured in AI healthcare stock roundup
Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.
Heartflow featured in AI healthcare stock roundup. Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.